Sugammadex Amomed

sugammadex sodium · AOP Orphan Pharmaceuticals GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sugammadex Amomed, covering 2026-02-04 to 2026-02-04. Get the full timeline:

Most recent: EMA Authorised: Sugammadex Amomed (sugammadex sodium) — AOP Orphan Pharmaceuticals GmbH